Dysphagia in Parkinson's disease is responsive to levodopa

Parkinsonism Relat Disord. 2013 Mar;19(3):282-4. doi: 10.1016/j.parkreldis.2012.11.007. Epub 2013 Jan 18.

Abstract

The role of levodopa in the treatment of dysphagia in Parkinson's disease (PD) has recently been questioned. There are good reasons, however, to "question the question." In this essay, evidence from published literature and clinical experience is presented, as well as a critical review of the first meta-analysis to explore this issue. The evidence presented supports the traditional view that PD dysphagia is responsive to levodopa.

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Deglutition / drug effects*
  • Deglutition Disorders / drug therapy*
  • Deglutition Disorders / etiology
  • Evidence-Based Medicine
  • Humans
  • Levodopa / therapeutic use*
  • Parkinson Disease / complications
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Levodopa